Karyopharm Therapeutics (KPTI) Tops Q2 EPS by 1c; Offers FY22 Revenue Guidance
Go back to Karyopharm Therapeutics (KPTI) Tops Q2 EPS by 1c; Offers FY22 Revenue Guidance| KARYOPHARM THERAP (NASDAQ: KPTI) | Delayed: 2.03 +0.04 (2.01%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.99 | 52 Week High | $19.41 | |||
| Open | $1.97 | 52 Week Low | $4.83 | |||
| Day High | $2.05 | P/E | N/A | |||
| Day Low | $1.97 | EPS | $-2.74 | |||
| Volume | 202,939 | |||||
